• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RAC

RACURA ONCOLOGY LTD - Charts / Financials

3.40% ! $2.27
Market Cap $427.0M  !

Racura Oncology (ASX: RAC) is a Phase 3 clinical biopharmaceutical company with a... Racura Oncology (ASX: RAC) is a Phase 3 clinical biopharmaceutical company with a dedicated mission to be at the heart of cancer care.More

Corporate Spotlight

Racura Oncology (ASX: RAC) is a Phase 3 clinical biopharmaceutical company with a dedicated mission to be at the heart of cancer care.
View the full Corporate Spotlight arrow Created with Sketch.

INSIDE RACURA ONCOLOGY - 2026 OUTLOOK
refresh Created with Sketch. REFRESH
Last update - 16.13pm 12/03/2026 (20 minute delay) ?
Day
Open $2.40   Day High $2.40   Day Low $2.26
Daily Volume 94196
Bids   Sellers
Number Price Volume   Number Price Volume
0 $2.28 285   0 $2.32 4000

Directors & Senior Management

Dr. Borje S. Andersson Chairman of Clinical Advisory Board
Mr. Brendan Brown Chief Financial Officer
Mr. Brendan Brown Chief Financial Officer
Dr. Daniel Douglas Von Hoff Clinical Advisory Board
Dr. Daniel Tillett CEO, MD & Director
Dr. Daniel Tillett Chief Executive Officer, Managing Director
Dr. Douglas Smith Member of Scientific Advisory Board
Associate Prof. Erin Howden Member of Scientific Advisory Board
Dr. Jaap-Jan Boelens Member of Clinical Advisory Board
Dr. James Breitenbucher Member of Scientific Advisory Board
Prof. Jianjun Chen Member of Scientific Advisory Board
Dr. Jose L. Iglesias Chief Medical Officer
Dr. Laurence H. Hurley Member of Scientific Advisory Board
Dr. Martin S. Tallman Member of Scientific Advisory Board
Dr Megan Baldwin Non-Executive Director
Dr. Megan Baldwin Independent Non-Executive Director
Mr. Peter Gordon Webse Company Secretary
Dr. Peter Michael Smith Executive Chairman
Dr. Roland Walter Member of Scientific Advisory Board
Dr. Serge Scrofani Non-Executive Director
Dr. Serge Scrofani Independent Non-Executive Director
Dr. Sophia Moscovis Vice President of Operations & Strategy
Dr. Sophia Moscovis Vice President of Operations and Strategy

Data source: ADVFN

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$2.27
Change
-0.080(3.40%)
Mkt cap ! $427.0M
Open High Low Volume
$2.40 $2.40 $2.26 94.19K

Buyers (Bids)

Vol. Price($)
285 $2.28
 

Sellers (Offers)

Price($) Vol.
$2.32 4000
Last trade - 16.13pm 12/03/2026 (20 minute delay) ?
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.